The nuclear factor k light-chain enhancer of activated B cells (NF-kB) pathway regulates many cellular processes, such as proliferation, apoptosis, stress responses, inflammation, ectodermal development, and immune responses. 1, 2 As such, NF-kB signaling plays a key role in inflammatory diseases, and mutations in several NF-kB components cause primary immunodeficiency or ectodermal dysplasia. [3] [4] [5] [6] [7] [8] [9] [10] [11] The NF-kB transcription factor family consists of 5 Rel proteins, p50/p105, p52/p100, RelA, RelB, and c-Rel, which dimerize with each other and drive or inhibit gene expression in the nucleus. 12 The canonical NF-kB pathway is triggered by microbial products or the cytokines IL-1b and TNF and progresses through phosphorylation-dependent degradation of NF-kB inhibitor a (IkBa). IkBa phosphorylation is mediated by the inhibitor of kB kinase (IKK) complex, which includes IKKa and IKKb and the regulatory protein NF-kB essential modulator (NEMO). This releases RelA-and c-Rel-containing dimers to enter the nucleus and drive transcription of proinflammatory genes.
13
NFKB1 encodes for p105, which is processed by the proteasome to generate the p50 transcription factor. p50 can heterodimerize with RelA or c-Rel and activate canonical NF-kB signaling or form homodimers that function as repressors of proinflammatory gene expression. 14, 15 The full-length p105 inhibits NF-kB signaling by binding to and inhibiting nuclear entry of RelA, c-Rel, and p50 through ankyrin repeats in the C-terminal half of the protein. 16, 17 Recently, haploinsufficiency of p50 was shown to cause antibody deficiency. 3 Common variants in NFKB1 also associate with inflammatory bowel disease and Behçet disease, a vasculitis of largely unknown cause characterized by recurrent oral and genital aphthous ulcers, uveitis, and skin lesions. [18] [19] [20] [21] [22] Here we describe heterozygous NFKB1 mutations (H67R, p.R157X, and I553M) in 3 Finnish kindreds that variably display dominantly segregating antibody deficiency, recurrent infections, and autoinflammatory features, including Behçet-like disease and hyperinflammatory reactions. Our results show that disease can ensue from dysregulation of NF-kB signaling caused by mutations affecting either p50 or p105.
METHODS

Study participants
The study was conducted in accordance with the principles of the Helsinki Declaration and was approved by the Helsinki University Central Hospital Ethics Committee. Written informed consent was obtained from patients and healthy control subjects.
DNA extraction and genetic analysis
Genomic DNA was extracted from EDTA blood samples by using the Qiagen FlexiGene DNA kit (Qiagen, Hilden, Germany). HLA-B*51 typing was performed in an accredited (European Federation for Immunogenetics) histocompatibility testing laboratory, the Finnish Red Cross Blood Service.
Generation and processing of sequencing libraries, read mapping, variant calling, genome annotation, and variant filtering, as well as genotyping and linkage analysis, are described elsewhere 23 Table E1 in this article's Online Repository at www.jacionline.org.
Computational modeling
Modeling of mutant amino acid residue effects was performed with the Coot single-mutation option (version 0.8.1, http://scripts.iucr.org/cgi-bin/paper? S0907444904019158) 24 and PyMol (Schr€ odinger). Crystallographic images were downloaded from the RCSB Protein Data Bank (www.rcsb.org). 25 
Experiments on patient-derived cells
PBMCs were isolated from patients' blood by using Ficoll-Paque gradient centrifugation. Whole protein was extracted by means of cell lysis in RIPA buffer, and expression of p50/p105 and RelA was detected by means of Western blotting (WB) with anti-p50/p105 and RelA antibodies (nos. 3035 and 8242, respectively; Cell Signaling Technology, Danvers, Mass). Glyceraldehyde-3-phosphate dehydrogenase antibody (no. 258; Thermo Fisher Scientific, Waltham, Mass) was used as a loading control. IRDye 800CW and 680LT secondary antibodies were used for signal detection with the Odyssey CLx Imaging System (LI-COR Biosciences, Lincoln, Neb). Lymphocyte immunophenotyping, inflammasome activation, and ELISAs are described in the Methods section in this article's Online Repository.
Generation of mutation constructs and cell lines
The wild-type (WT), H67R, and I553M mutant NFKB1 full-length coding sequences were commercially cloned into a Gateway-compatible entryvector (GenScript, Piscataway, NJ). R157X and A156S mutations were generated by using PCR from the WT template. For transient and stable expression, constructs were subcloned into the pcDNA-DEST40 expression Vector (Thermo Fisher Scientific) and pTO_HA_StrepIII_N_GW_FRT (SH-tag) or pTO_Myc_BirA_N_GW_FRT (BioID) vectors, respectively. 26 Constructs were transfected into Flp-In T-REx 293 cells to generate tetracycline-inducible isogenic cell lines (Life Technologies, Grand Island, NY). 27 Construct expression on tetracycline induction (2 mg/mL) was confirmed by means of mass spectrometry and WB with anti-p50/p105 and anti-hemagglutinin (HA.11; Covance, Princeton, NJ) antibodies. a-Tubulin antibody (ab7291; Abcam, Cambridge, United Kingdom) was used as a loading control. 
Proteasome inhibition
Tetracycline-induced (2 mg/mL for 20 hours) WT and R157X-p50/p105-Flp-In T-REx 293 cells were treated with the proteasome inhibitor MG132 (474790; Merck Millipore, Billerica, Mass) for 4 hours in 0, 5, 10, or 20 mmol/L concentrations. Cells were lysed, and p50/p105 levels were assessed by using WB.
Luciferase reporter assays
Tetracycline-treated p50/p105-Flp-In cells were transfected (on 96-well plates in triplicate) with a p50:RelA-responsive firefly luciferase reporter plasmid 28 and a constitutively expressed pRL-TK Renilla luciferase control reporter using FuGENE HD (Promega, Madison, Wis). For transient transfections, HEK293 cells were cotransfected with the reporters and pcDNA-DEST40-p50/p105 vectors. Signaling was activated with TNF (10 or 25 ng/ mL for 16 hours). Luminescence was measured with the Dual-Glo Luciferase Assay System (Promega) and PHERAstar Plate Reader (BMG Labtech, Ortenberg, Germany). The NF-kB/control plasmid signal ratio was calculated to account for differences in cell numbers, and these data were normalized to the uninduced WT sample. Results were pooled from 2 to 4 repeats of each assay. The t test was used to calculate P values.
Immunofluorescence assay
The p50/p105-Flp-In cell lines were seeded on coverslips coated with rattail collagen (Thermo Fisher Scientific). Tetracycline-treated cells were induced with TNF (10 or 25 ng/mL for 40 minutes), fixed in paraformaldehyde, and blocked with 1% BSA-PBS (Sigma-Aldrich). The HA.11 antibody was used for detection of tagged p50/p105 with anti-mouse Alexa Fluor 488 (A-11029, Life Technologies) secondary antibody. Nuclei were stained with 49-6-diamidino-2-phenylindole (D9542-5MG, Sigma-Aldrich). Imaging was performed at 340 magnification with the Axio Imager.Z2 (Zeiss, Oberkochen, Germany) and the Nuance multispectral imaging system FX (PerkinElmer, Waltham, Mass). ImageJ software (National Institutes of Health, Bethesda, Md) was used for quantification of signal intensities. 29 Three hundred to 600 cells per condition were analyzed.
Affinity purification, BioID, mass spectrometry, and protein quantification
For each single-step Strep-tag affinity purification and BioID 30 experiment, approximately 5 3 10 7 cells (2 biological and technical replicates) from the p50/ p105-Flp-In cells were induced with tetracycline (2 mg/mL for 24 hours) with or without TNF (10 ng/mL for 90 minutes). Cysteine bonds were reduced with 5 mmol/LTris(2-carboxyethyl)phosphine and alkylated with 10 mmol/L iodoacetamide, and proteins were digested to peptides with sequencing-grade trypsin (Promega). Peptides were purified with C-18 MicroSpin Columns (The Nest Group, Southborough, Mass). After vacuum concentration, dried samples were dissolved in 30 mL of buffer A. 27 Mass spectrometric analyses of samples were performed with a 60-minute linear gradient on an Orbitrap Elite ETD Hybrid Mass Spectrometer coupled to the EASY-nLC II System (Thermo Scientific). Proteins were identified and quantified by using the Andromeda search engine and MaxQuant proteomics software. 31, 32 Raw data were searched against the human component of the UniProtKB-database (release 2014_11). Results were filtered to a maximum false discovery rate of 0.05. For phosphopeptide identification, phosphorylation (Ser, Thr, and Tyr) was included as a variable modification in MaxQuant/Andromeda. Filtering parameters for 2 accepted phosphopeptides (QMGYTEAIEVIQAASSPVK modified at serine 893 and TTSQAHSLPLSPASTR with 1 or 2 phosphorylations at serines 907 and/or 903) and a more detailed description of the analyses are found in the Methods section in this article's Online Repository.
RESULTS
Identification of NFKB1 variants in 3 families with immunodeficiency and autoinflammation
We studied a cohort of unsolved primary immunodeficiency cases representing a broad spectrum of immunologic phenotypes with next-generation sequencing methods to identify the causal genes. Independent genetic analyses revealed novel heterozygous NFKB1 variants as the most likely cause of disease in 3 families from this cohort.
Family 1 included 9 affected subjects who presented with recurrent respiratory tract infections and progressive B-cell dysfunction marked by hypogammaglobulinemia, poor antibody response to anti-pneumococcal vaccines, or decreased switched memory B-cell counts (Fig 1, A and B ; Table I; and see Tables E2-E5 in this article's Online Repository at www.jacionline.org). Recurrent episodes of aphthous mucositis in the upper gastrointestinal and genital areas, which were sometimes accompanied by abdominal pain, monoarthritis, or fever with increased inflammatory markers (peripheral blood leukocytes, >10 3 10 6 cells/mL; C-reactive protein, >100 mg/L), were frequent (Fig 1, C and D, and see Fig E2 in this article's Online Repository at www.jacionline.org). Lesional biopsy specimens from 2 family members revealed lymphocytic small-vessel vasculitis (Fig 1, E) , supporting a clinical diagnosis of Behçet disease. In 2 affected family members routine surgical procedures led to a hyperinflammatory state consisting of fever and excessive inflammation in the wound area.
We performed genotyping and linkage analysis on 10 subjects from this family to identify regions of interest, followed by whole-genome sequencing of 2 subjects (F1. In family 2 mother and son (F2.II-3 and F2.III-2 in Fig 1) presented with recurrent respiratory tract and other severe infections, hypogammaglobulinemia, and poor antibody responses to polysaccharide vaccines. Both patients had inflammatory gastrointestinal disease, and the mother experienced multiorgan autoimmunity with thyroiditis, enteropathy, spondyloarthropathy, and urticaria. The mother's father had succumbed to similar symptoms before the study. We performed whole-exome sequencing on patient F2.II-3 and filtered the data for novel heterozygous variants affecting conserved residues. Of 10 surviving variants (see Table E6 in this article's Online Repository at www.jacionline.org), a variant in NFKB1 (NM_003998: c.C1659G/p.I553M) was the most attractive based on known protein functions. 33, 34 The variant localizes to the ankyrin repeat region at the C-terminal half of p105 and was predicted to affect its posttranslational processing and proteinprotein interactions (Fig 2) . Sanger sequencing confirmed the presence of the variant in the affected son of the proband.
Two affected brothers in family 3 (F3.II-1 and F3.II-5) had postoperative deep necrotizing cellulitis with abscesses, fever, neutrophilia, and increased inflammatory markers that required prolonged intensive care and multiple surgical revisions (Fig 1, A , B, and F, and see Fig E2) . No pathogenic bacteria could be cultured from the affected sites. Although these patients' switched memory B-cell counts were less than the reference range, they had normal immunoglobulin levels and did not show increased susceptibility to infection. Analysis of their whole-exome sequencing data identified a novel stop-gain variant in NFKB1 (NM_003998: c.C936T/p.R157X). Targeted Sanger sequencing detected this variant also in 2 asymptomatic siblings and their mother.
Because of Behçet-like symptoms in family 1, all symptomatic NFKB1 mutation carriers were genotyped for the Behçet syndrome-associated HLA B*51:01 allele. 22 Several subjects in family 1 (F1.III-2, F1.IV-1, F1.IV-2, F1.III-3, and F1.III-8) were found to carry this allele, but carriership did not cosegregate with Behçet-like symptoms, leaving the significance of this allele to the phenotype unclear.
Immunologic findings of the NFKB1 mutation carriers
The participants underwent extensive blood immunophenotyping, which showed rather wide interindividual variation (see Tables E2-E5) . However, most patients exhibited chronic mild leukocytosis (9-10 3 10 9 /L), with the affected p.R157X carriers presenting with very high counts (50-60 3 10 9 /L, with the increase being mostly neutrophils) during inflammatory episodes. Patients from the first 2 families (p.H67R and p.I553M) were hypogammaglobulinemic or presented with IgG subclass deficiency; additionally, 8 of 9 tested subjects had nonprotective responses to pneumococcal polysaccharide. Most patients, even the p.R157X carriers lacking clinical antibody deficiency, had low switched memory B-cell counts, with a corresponding increase in naive B-cell counts. On examination of T-cell subsets, we noted low CD4
1 effector memory T-cell counts and effector memory RA T-cell counts (CCR7 2 ) in several patients. In addition, some (4/8) of the tested patients had moderately increased IFN-g and TNF secretion on T-cell stimulation.
The R157X mutant causes depletion of p50/p105 and excessive production of IL-1b
The effect of NFKB1 mutations on p50/p105 expression was estimated by using WB of PBMC-derived protein extracts from patients and age/sex-matched control subjects. Protein amounts in patients with missense mutations were comparable with those in control subjects, but patients with the R157X mutation showed significant depletion of p50, p105, and RelA (Fig 3, A, and see Fig E5, A and B , in this article's Online Repository at www.jacionline.org). ELISA for active p50 and RelA on patients' PBMC-derived nuclear protein produced similar results (see Fig  E5, C and D) . Because NF-kB is involved in regulation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome and excessive inflammasome activation is involved in the pathogenesis of several autoinflammatory diseases, we compared inflammasome activation in LPS-primed macrophages derived from patients and healthy control subjects. After ATP-induced inflammasome activation, macrophages from patients with the R157X mutation displayed significantly increased secretion of IL-1b, whereas those with the H67R mutation showed a trend toward decreased IL-1b secretion (Fig 3, B) . In LPS-induced R157X macrophages, quantitative real-time RT-PCR revealed higher expression of pro-IL-1b compared with that seen in control subjects also at the mRNA level, whereas no difference in NLRP3 expression was observed (see Fig E6 in this article' s Online Repository at www.jacionline.org).
To study the effects of the mutations further, we constructed Flp-In T-REx 293 cell lines stably expressing WT or mutant p50/p105 under a tetracycline-inducible promoter. Equal expression of WT and missense constructs was confirmed by using WB (Fig 3, C) , whereas expression of the truncated R157X mutant protein was only detected in transiently transfected cells after a long exposure time (see Fig E7 in this article's Online Repository at www.jacionline.org). Despite this, overexpression of this construct caused a marked reduction in endogenous p50 and p105, an effect alleviated by treatment with proteasome inhibitors (Fig 3, D 
H67R and R157X mutants show reduced NF-kB activation
The p50/p105-Flp-In cell lines were transiently transfected with an NF-kB-responsive firefly luciferase reporter and a constitutively active Renilla luciferase control reporter to test the effect of the NFKB1 mutations on NF-kB transcriptional activity and to control for cell viability, respectively. Reporter activities were measured after induction of signaling with TNF. Overexpression of the WT and I553M constructs increased NF-kB reporter activity comparably, whereas overexpression of the H67R mutant did not increase reporter activity to greater than the signal from the endogenous protein, indicating loss of function (Fig 3, F) . As expected, overexpression of the R157X stop-gain mutant also did not increase signaling. Transient transfections of WT, H67R, and I553M expression constructs into HEK293 cells produced similar results but, interestingly, also decreased cell viability compared with the WT construct (see Fig E9 in 
R157X
Rel homology domain FIG 2 . p50/p105 protein structure and structural representation of mutated sites. A, Schematic illustration of p50/p105 structure with corresponding protein domains (up) and the fold (below). Mutated residues are shown with vertical bars. B, Crystallographic structure of p50 (figure based on Protein Data Bank entry 1SVC, residues 62-352). Normally, the H67 residue interacts with DNA through a water molecule (red ball). The mutant 67R has 4 different conformations (shown in magenta) that affect the distance of the residue from DNA. One of them reaches DNA directly, removing the mediator water molecule. C, Crystallographic representation of p105 before cleavage (reconstructed from Protein Data Bank entries 1NFI and 1SVC). The I553M mutation (green) affects the hydrophobic contact surfaces of the ankyrin repeat domain (violet). For both Fig 2, B and C, a close up of the WT state is featured in the red box, and the mutated state is featured in the blue box.
NFKB1 mutants exhibit altered protein-protein interactions
The p50/p105-Flp-In cell lines were used to map protein-protein interactions of mutant and WT p50/p105 by means of affinity purification mass spectrometry (Fig 4 and see Fig E10 and Table  E7 in this article's Online Repository at www.jacionline.org). This revealed 17 high-confidence protein-protein interactions, of which 2, Myc-associated zinc finger protein (MAZ), and IlvBlike protein (ILVBL), were previously undescribed. All interactions were verified by using BioID, which detected an additional transient signal transducer and activator of transcription 3 interaction. Both missense mutants showed an altered interaction profile both without and with TNF stimulation. Notably, in unstimulated cells we observed decreased affinity between the H67R mutant with RelB increased in response to pathway activation in WT (1.63) and the H67R mutant (1.28), no change in RelB affinity was observed with the I553M mutant. With the R157X mutant, similar to A156Sfs-NFKB1 mutant, only very few peptides of the protein were present, and only an interaction with MAZ was detected (see Table E8 in this article's Online Repository at www.jacionline.org). From PBMCs of patients with R157X mutation, only N-terminal peptides were detected from antibody-based 
H67R mutant displays reduced nuclear localization
We asked whether increased binding between NEMO and the H67R mutant would affect p50 nuclear localization. By using the p50/p105-Flp-In cell lines, we performed immunofluorescence staining and microscopy after induction with TNF (10 or 25 ng/mL for 40 minutes). An anti-hemagglutinin antibody was used to visualize only tagged proteins. Although addition of 25 ng/mLTNF caused a 1.5-to 2-fold increase in nuclear localization in all cell lines, 10 ng/mL TNF induced nuclear localization of the WT and I553M proteins, but not of the H67R mutant, suggesting a reduction in efficiency of nuclear localization by this mutant (Fig 5) .
I553M mutation alters posttranslational processing of p105
To study whether the I553M mutation affects the stability of p105, we performed a TNF titration on the mutant cell lines (Fig  6, A) . In unstimulated conditions, p105 and p50 were expressed equally. However, with increasing TNF concentrations, the amount of I553M-p105 decreased more than that of WT or H67R-p105. Because degradation of p105 during pathway induction by TNF is mediated by phosphorylation, 35, 36 we tested whether the I553M mutation alters p105 phosphorylation.
To assess this, we identified and quantified phosphopeptides from the affinity purification mass spectrometry data of WT and mutant p50/p105 using the Andromeda search engine combined with MaxQuant. Two peptides of p105 with a total of 3 serine residues (S893, S903, and S907) were identified and quantified in all replicates (see Table E9 in this article's Online Repository at www.jacionline.org). The I553M mutation caused a significant decrease in S893 and S907 phosphorylation (Fig 6, B) . The first peptide (amino acids 878-896) was phosphorylated at serine 893, and the second peptide (amino acids 897-912) was found to be either singly phosphorylated at serine 907 or double phosphorylated at serines 907 and 903. Compared with the WT protein, the phosphorylation status of both S893 and S907 was significantly decreased (with a relative amount of phosphorylated to unphosphorylated peptide at 0.65 and 0.67, respectively) in the I553M mutant. 
DISCUSSION
In this study we identified heterozygous NFKB1 mutations in 3 families presenting with varying combinations of antibody deficiency, Behçet-like disease, and life-threatening postoperative complications of autoinflammatory origin. Furthermore, we showed that these mutations functionally affect the NF-kB subunits p50 and p105.
Haploinsufficiency of p50 was recently shown to cause common variable immunodeficiency, but none of the previously reported cases had autoinflammatory symptoms. 3, 37 However, an immunodysregulatory phenotype is well demonstrated in p50/p105-deficient mouse models. NFKB1 2/2 mice have multiorgan autoimmunity and show increased IL-6 production, activation of autoreactive CD8
1 T cells, and defective maturation of immunoregulatory natural T lymphocytes. [38] [39] [40] [41] [42] Similar to some of our patients, the mice produce increased amounts of the proinflammatory cytokines IFN-g and TNF.
43-45 p50 regulates TNF production, and TNF controls intestinal inflammation and epithelial cell turnover in the colon. 44, 46, 47 Hence increased TNF production might contribute to the gastrointestinal symptoms in our patients. TNF-induced apoptosis and necrosis could also contribute to inflammatory symptoms by compromising mucosal barrier function and increasing tissue degeneration at inflamed sites. [48] [49] [50] Defects in other molecules of the NF-kB signaling pathway also lead to inflammation in human subjects: NEMO deficiency can cause systemic inflammation, enterocolitis, and Behçet disease. [51] [52] [53] [54] Moreover, haploinsufficiency of A20, a negative regulator of NF-kB signaling, causes Behçet-like symptoms, and IkBa mutations can present with noninfectious inflammation. 9, 55 Hence autoinflammatory symptoms in patients with NFKB1 mutations are not surprising.
Phenotypes of patients with the now reported NFKB1 mutations varied between subjects, but variable disease severity has also been reported by others. 37 Genetic factors, such as common variants in immunologically relevant genes, and environmental effects, such as pathogens or immunomodulatory treatments, are likely partially responsible for these differences. Patient age can also factor in because our young patients had only mild disease, and most affected carriers were asymptomatic as children. Indeed, animal age affects the phenotype and immune cell numbers also in NFKB1 2/2 mice. 38 In addition, we detected molecular differences between the now identified and previously described NFKB1 mutations. 3 In our cell model the R157X mutant induced degradation of the endogenous p50/p105 through a proteasome-dependent mechanism, whereas the A156Sfs mutant did not. The binding of mutant R157X protein to nascent WT p50/p105 could lead to misfolding and degradation of both peptides because dimerization of p50 and p105 is required for their stabilization and folding. 56 Despite the severe insufficiency of p50/p105, only some of the R157X variant carriers had hyperinflammatory reactions, and none had antibody Suggested mechanisms of signaling disturbance by NFKB1 missense mutations. In normal conditions p50 forms both proinflammatory heterodimers and anti-inflammatory homodimers. The R157X mutation reduces the amount and the H67R mutation reduces the activity of both types of dimers, likely dysregulating both initiation and termination of proinflammatory gene transcription. The I553M mutant might increase p50 concentration in the nucleus because p105 is an important regulator of p50 homodimers. In addition, reduction in p105 can increase signaling through extracellular signal-regulated kinase (ERK) because p105 regulates mitogen-activated protein kinase (MAPK)/ERK signaling through inhibition of tumor progression locus 2. The inhibited MAPK-ERK pathway downregulates overall NF-kB signaling.
J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 3 deficiency. Although p50 is necessary for immunoglobulin diversification in mice, 33, 57 compensatory mechanisms might exist to maintain normal antibody production in cases of p50 insufficiency in human subjects.
The R157X mutation carriers had life-threatening postoperative complications. Macrophages derived from these patients exhibited increased inflammasome activation and IL-1b secretion. Priming of the NLRP3 inflammasome in macrophages is mediated by NF-kB, but the NF-kB/p62/mitophagy pathway can also restrict the secretion of IL-1b and consequently attenuate sterile inflammation. 58, 59 Hence p50 deficiency in macrophages can promote IL-1b production and lead to tissue inflammation. In addition, increased neutrophil recruitment was detected both in NFKB1 2/2 mice and in carriers of the R157X mutation during inflammatory episodes, which exacerbates disease and contributes to tissue damage. [60] [61] [62] The H67R mutation impaired p50 transcriptional activity. p50 is bound by NEMO, which keeps p50 in the cytoplasm and releases it to enter the nucleus on NF-kB activation. Our data suggest increased binding between the mutant p50 and NEMO, resulting in impairment of p50 nuclear entry. The disease could be caused by a diminished pool of transcriptionally active p50 heterodimers (Fig  7) , as has been seen in previously reported cases of p50 haploinsufficiency. However, autoinflammatory symptoms could also be due to reduced numbers of p50:p50 homodimers, which normally curb inflammatory reactions by repressing inflammatory and inducing anti-inflammatory gene expression. 15, 63, 64 Patients with the I553M mutation had common variable immunodeficiency, phenotypically resembling Fliegauf et al's cohort. 3 In contrast to their data, we did not detect changes in p50 quantity or activity. Instead, we observed decreased phosphorylation and increased degradation of I553M-p105. p105 degradation is induced by TNF and leads to release of p50 and other NF-kB transcription factors. Thus a decrease in p105 can affect activation or termination of downstream signaling. 65 In mice loss of p105 is sufficient to cause inflammation and infection susceptibility. 34 Additionally, we detected altered protein interaction profiles between WT and mutant p105. Loss of interaction between I553M-p105 and IkBε on the NF-kB pathway activation might contribute to the phenotype because hematopoietic IkBε regulates chronic inflammation. 66 Both I553M and H67R mutants also showed reduced interactions with RelB. Expression of RelB is activated by canonical NF-kB signaling, and the lost interaction might merely indicate reduced canonical pathway activation in mutant cells. 67 In response to activation of the nonclassical NF-kB pathway, RelB dimerizes with p52 encoded by NFKB2, mutations that cause common variable immunodeficiency. 6 By contrast, functions of p50:RelB dimers are largely uncharted, but in dendritic cells and macrophages they regulate expression and activation of certain anti-inflammatory genes. [68] [69] [70] In conclusion, we broaden the phenotype of NFKB1 mutations, showing that certain patients can have autoinflammatory disease in combination with antibody deficiency. Increased production of TNF and IL-1b during autoinflammatory episodes suggests a potential therapeutic venue for IL-1 and TNF inhibitors in severe cases. Moreover, we show that mutations affecting only p105 are sufficient to cause hypogammaglobulinemia and autoimmunity. These results highlight the importance of p50/p105 for proper immune function and control of inflammation. 
